Professor Alan P. Kozikowski, Ph.D. | Source | Chief Scientific Officer at PurMinds NeuroPharma

Alan P. Kozikowski is an American medicinal chemist, drug designer, and pharmaceutical entrepreneur, best known for his research on 5-HT receptors, and GSK-3 inhibitors. He is an author of a book Drug Design for Neuroscience. He has over 100 patents, over 550 publications. He was educated on the University of Michigan (BS Honors in Chemistry), University of California, Berkeley (PhD in Organic Chemistry), and did postdoctoral studies at Harvard University.

Alan P. Kozikowski, Ph.D., serves as the Chief Scientific Officer at PurMinds Neuropharma, a pioneering firm dedicated to advancing neuroscientifically-informed therapies for neurological conditions. With an illustrious career spanning over four decades, Dr. Kozikowski has distinguished himself as a leading medicinal chemist and pharmaceutical entrepreneur, known for his groundbreaking work on 5-HT receptors, HDAC inhibitors, GSK-3 inhibitors, Prostate Specific Membrane Antigen (PSMA) inhibitors, and more.